Redox proteomics: From protein modifications to cellular dysfunction and disease

Mass Spectrometry Reviews

Volumn 33, Issue 1, 2014, Pages 1-6

  Butterfield, D Allan ^a   Dalle Donne, Isabella ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT DEFENSE; BIOLOGICAL FUNCTIONS; BIOLOGICAL MOLECULE; CELLULAR DYSFUNCTION; CELLULAR MOLECULES; LOW CONCENTRATIONS; PROTEIN MODIFICATIONS; REACTIVE OXYGEN AND NITROGEN SPECIES;

MOLECULAR BIOLOGY; NUCLEIC ACIDS; POLYUNSATURATED FATTY ACIDS; REPAIR; TOXICITY;

PROTEINS;

PROTEIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; CHEMISTRY; HUMAN; METABOLISM; METHODOLOGY; OXIDATION REDUCTION REACTION; PROTEOMICS;

ANIMALS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; OXIDATION-REDUCTION; PROTEINS; PROTEOMICS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84891511098     PISSN: 02777037     EISSN: 10982787     Source Type: Journal    
DOI: 10.1002/mas.21404     Document Type: Article

References (92)

1. Aebersold R,. 2003. Constellations in a cellular universe. Nature 422: 115-116.
2. Aiken CT, Kaake RM, Wang X, Huang L,. 2011. Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics 10: R110.006924.
3. Alderson NL, Wang YP, Blatnik M, Frizzell N, Walla MD, Lyons TJ, Alt N, Carson JA, Nagai R, Thorpe SR, Baynes JW,. 2006. S-(2-Succinyl)cysteine: A novel chemical modification of tissue proteins by a krebs cycle intermediate. Arch Biochem Biophys 450: 1-8.
4. Arena S, Renzone G, Salzano AM, D'Ambrosio C, Scaloni A,. 2013. Non-enzymatic glycation and glycoxidation protein products in foods and diseases: An interconnected, complex scenario fully open to innovative proteomic studies. Mass Spectrom Rev 33: 49-77.
5. Bachi A, Dalle-Donne I, Scaloni A,. 2013. Redox proteomics: Chemical principles, methodological approaches and biological/biomedical promises. Chem Rev 113: 596-698.
6. Barreiro E,. 2013. Protein carbonylation in skeletal muscle of COPD patients. Mass Spectrom Rev 33: DOI: 10.1002/mas.21394
7. Barreiro E, Hussain SN,. 2010. Protein carbonylation in skeletal muscles: Impact on function. Antioxid Redox Signal 12: 417-429.
8. Bossy-Wetzel E, Schwarzenbacher R, Lipton SA,. 2004. Molecular pathways to neurodegeneration. Nat Med 10: S2-S9.
9. Brandes N, Schmitt S, Jakob U,. 2009. Thiol-based redox switches in eukaryotic proteins. Antioxid Redox Signal 11: 997-1014.
10. Butterfield DA, Dalle-Donne I,. 2012. Redox proteomics. Antioxid Redox Signal 17: 1487-1489.
11. Butterfield DA, Kanski J,. 2001. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mech Ageing Dev 122: 945-962.
12. Butterfield DA, Stadtman ER,. 1997. Protein oxidation processes in aging brain. Adv Cell Aging Gerontol 2: 161-191.
13. Butterfield DA, Reed T, Sultana R,. 2011. Roles of 3-nitrotyrosine- and 4-hydroxynonenal-modified brain proteins in the progression and pathogenesis of Alzheimer's disease. Free Radic Res 45: 59-72.
14. Butterfield DA, Perluigi M, Reed T, Muharib T, Hughes CP, Robinson RA, Sultana R,. 2012. Redox proteomics in selected neurodegenerative disorders: From its infancy to future applications. Antioxid Redox Signal 17: 1610-1655.
15. Butterfield DA, Gu L, Di Domenico F, Robinson RAS,. 2013. Mass spectrometry and redox proteomics: Applications in disease. Mass Spectrom Rev 33: DOI: 10.1002/mas.21374
16. Cabiscol E, Tamarit J, Ros J,. 2013. Protein carbonylation: Proteomics, specificity and relevance to aging. Mass Spectrom Rev 33: 21-48.
17. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Giuffrida Stella AM,. 2007. Nitric oxide in the nervous system: Neuroprotection vs. neurotoxicity. Nat Rev Neurosci 8: 766-775.
18. Castro JP, Ott C, Jung T, Grune T, Almeida H,. 2012. Carbonylation of the cytoskeletal protein actin leads to aggregate formation. Free Radic Biol Med 53: 916-925.
19. Castro JP, Jung T, Grune T, Almeida H,. 2013. Actin carbonylation: From cell dysfunction to organism disorder. J Proteomics pii: S1874-3919(13)00241-8, doi: 10.1016/j.jprot.2013.05.006
20. Català A,. 2009. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 157: 1-11.
21. Charles R, Jayawardhana T, Eaton P,. 2013. Gel-based methods in redox proteomics. Biochim Biophys Acta pii: S0304-4165(13)00149-9, doi: 10.1016/j.bbagen.2013.04.021
22. Codreanu SG, Zhang B, Sobecki SM, Billheimer DD, Liebler DC,. 2009. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol Cell Proteomics 8: 670-680.
23. Colombo G, Clerici M, Giustarini D, Rossi R, Milzani A, Dalle-Donne I,. 2012a. Redox albuminomics: Oxidized albumin in human diseases. Antioxid Redox Signal 17: 1515-1527.
24. Colombo G, Dalle-Donne I, Orioli M, Giustarini D, Rossi R, Clerici M, Regazzoni L, Aldini G, Milzani A, Butterfield DA, Gagliano N,. 2012b. Oxidative damage in human gingival fibroblasts exposed to cigarette smoke. Free Radic Biol Med 52: 1584-1596.
25. Colombo G, Clerici M, Giustarini D, Portinaro NM, Aldini G, Rossi R, Milzani A, Dalle-Donne I,. 2013. Pathophysiology of tobacco smoke exposure: Recent insights from comparative and redox proteomics. Mass Spectrom Rev 33: DOI: 10.1002/mas.21392
26. Colzani M, Aldini G, Carini M,. 2013. Mass spectrometric approaches for the identification and quantification of reactive carbonyl species protein adducts. J Proteomics pii: S1874-3919(13)00177-2.
27. D'Autreaux B, Toledano MB,. 2007. ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 8: 813-824.
28. Dalle-Donne I, Rossi R, Giustarini D, Gagliano N, Lusini L, Milzani A, Di Simplicio P, Colombo R,. 2001. Actin carbonylation: From a simple marker of protein oxidation to relevant signs of severe functional impairment. Free Radic Biol Med 31: 1075-1083.
29. Dalle-Donne I, Giustarini D, Colombo R, Rossi R, Milzani A,. 2003. Protein carbonylation in human diseases. Trends Mol Med 9: 169-176.
30. Dalle-Donne I, Scaloni A, Giustarini D, Cavarra E, Tell G, Lungarella G, Colombo R, Rossi R, Milzani A,. 2005. Proteins as biomarkers of oxidative/nitrosative stress in diseases: The contribution of redox proteomics. Mass Spectrom Rev 24: 55-99.
31. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A,. 2006a. Biomarkers of oxidative damage in human disease. Clin Chem 42: 601-623.
32. Dalle-Donne I, Aldini G, Carini M, Colombo R, Rossi R, Milzani A,. 2006b. Protein carbonylation, cellular dysfunction, and disease progression. J Cell Mol Med 10: 389-406.
33. Dalle-Donne I, Scaloni A, Butterfield DA,. 2006c. Redox proteomics: From protein modifications to cellular dysfunction and disease. Hoboken: John Wiley & Sons, Inc. 944p.
34. Dalle-Donne I, Rossi R, Giustarini D, Colombo R, Milzani A,. 2007. S-Glutathionylation in protein redox regulation. Free Radic Biol Med 43: 883-898.
35. Dalle-Donne I, Rossi R, Colombo G, Giustarini D, Milzani A,. 2009. Protein S-glutathionylation: A regulatory device from bacteria to humans. Trends Biochem Sci 34: 85-96.
36. Dewaele M, Martinet W, Rubio N, Verfaillie T, de Witte PA, Piette J, Agostinis P,. 2011. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J Cell Mol Med 15: 1402-1414.
37. Di Domenico F, Sultana R, Ferree A, Smith K, Barone E, Perluigi M, Coccia R, Pierce W, Cai J, Mancuso C, Squillace R, Weingele M, Dalle-Donne I, Wolozin B, Butterfield DA,. 2012. Redox proteomics analyses of the influence of co-expression of wild type or mutated LRRK2 and tau on C. elegans protein expression and oxidative modification: Relevance to Parkinson disease. Antioxid Redox Signal 17: 1490-1506.
38. Erickson JR, Joiner ML, Guan X, Kutschke W, Yang J, Oddis CV, Bartlett RK, Lowe JS, O'Donnell SE, Aykin-Burns N, Zimmerman MC, Zimmerman K, Ham AJ, Weiss RM, Spitz DR, Shea MA, Colbran RJ, Mohler PJ, Anderson ME,. 2008. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133: 462-474.
39. Fedorova M, Bollineni RC, Hoffmann R,. 2013. Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies. Mass Spectrom Rev 33: DOI: 10.1002/mas.21381
40. Feeney MB, Schöneich C,. 2012. Tyrosine modifications in aging. Antioxid Redox Signal 17: 1571-1579.
41. Forman HJ, Maiorino M, Ursini F,. 2010. Signaling functions of reactive oxygen species. Biochemistry 49: 835-842.
42. Fritz KS, Petersen DR,. 2011. Exploring the biology of lipid peroxidation-derived protein carbonylation. Chem Res Toxicol 24: 1411-1419.
43. Fritz KS, Petersen DR,. 2013. An overview of the chemistry and biology of reactive aldehydes. Free Radic Biol Med 59: 85-91.
44. Furdui CM, Poole LB,. 2013. Chemical approaches to detect and analyze protein sulfenic acids. Mass Spectrom Rev 33: DOI: 10.1002/mas.21384
45. Ghesquiére B, Gevaert K,. 2013. Proteomics methods to study methionine oxidation. Mass Spectrom Rev 33: DOI: 10.1002/mas.21386
46. Grimm S, Hoehn A, Davies KJ, Grune T,. 2011. Protein oxidative modifications in the ageing brain: Consequence for the onset of neurodegenerative disease. Free Radic Res 45: 73-88.
47. Halliwell B,. 2011. Free radicals and antioxidants-Quo vadis ? Trends Pharmacol Sci 32: 125-130.
48. Halliwell B, Gutteridge J,. 2007. Free radicals in biology and medicine. Oxford, UK: Oxford University Press. 851p.
49. Haskew-Laytona RE, Payappilly JB, Smirnova NA, Ma TC, Chan KK, Murphy TH, Guo H, Langley B, Sultana R, Butterfield DA, Santagata S, Alldred AJ, Gazaryan IG, Bell GW, Ginsberg SD, Ratan RR,. 2010. Controlled enzymatic production of astrocytic hydrogen peroxide protects neurons from oxidative stress via an Nrf2-independent pathway. Proc Nat Acad Sci USA 107: 17385-17390.
50. Held JM, Gibson BW,. 2012. Regulatory control or oxidative damage? Proteomic approaches to interrogate the role of cysteine oxidation status in biological processes. Mol Cell Proteomics 11: R111.013037.
51. Higdon A, Diers AR, Oh JY, Landar A, Darley-Usmar VM,. 2012. Cell signalling by reactive lipid species: New concepts and molecular mechanisms. Biochem J 442: 453-464.
52. Ischiropoulos H,. 2009. Protein tyrosine nitration-An update. Arch Biochem Biophys 484: 117-121.
53. Jomova K, Vondrakova D, Lawson M, Valko M,. 2010. Metals, oxidative stress and neurodegenerative disorders. Mol Cell Biochem 345: 91-104.
54. Jung T, Grune T,. 2008. The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60: 743-752.
55. Kaushik S, Cuervo AM,. 2006. Autophagy as a cell-repair mechanism: Activation of chaperone-mediated autophagy during oxidative stress. Mol Aspects Med 27: 444-454.
56. Keeney JT, Swomley AM, Förster S, Harris JL, Sultana R, Butterfield DA,. 2013. Apolipoprotein A-I: Insights from redox proteomics for its role in neurodegeneration. Proteomics Clin Appl 7: 109-122.
57. Kiffin R, Christian C, Knecht E, Cuervo AM,. 2004. Activation of chaperone-mediated autophagy during oxidative stress. Mol Biol Cell 15: 4829-4840.
58. Kim G, Weiss SJ, Levine RL,. 2013. Methionine oxidation and reduction in proteins. Biochim Biophys Acta pii: S0304-4165(13)00193-1, doi: 10.1016/j.bbagen.2013.04.038
59. Kumar V, Kleffmann T, Hampton MB, Cannell MB, Winterbourn CC,. 2013. Redox proteomics of thiol proteins in mouse heart during ischemia/reperfusion using ICAT reagents and mass spectrometry. Free Radic Biol Med 58: 109-117.
60. Levine RL,. 2002. Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic Biol Med 32: 790-796.
61. Levine RL, Stadtman ER,. 2001. Oxidative modification of proteins during aging. Exp Gerontol 36: 1495-1502.
62. Liebler DC,. 2008. Protein damage by reactive electrophiles: Targets and consequences. Chem Res Toxicol 21: 117-128.
63. Lõpez-Sánchez LM, Lõpez-Pedrera C, Rodríguez-Ariza A,. 2013. Proteomic approaches to evaluate protein S-nitrosylation in disease. Mass Spectrom Rev 33: 7-20.
64. Madian AG, Regnier FE,. 2010. Proteomic identification of carbonylated proteins and their oxidation sites. J Proteome Res 9: 3766-3780.
65. Maron BA, Tang SS, Loscalzo J,. 2013. S-Nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal 18: 270-287.
66. Martínez A, Portero-Otin M, Pamplona R, Ferrer I,. 2010. Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates. Brain Pathol 20: 281-297.
67. Merkley ED, Metz TO, Smith RD, Baynes JW, Frizzell N,. 2013. The succinated proteome. Mass Spectrom Rev 33: DOI: 10.1002/mas.21382
68. Murakami H, Guillet C, Tardif N, Salles J, Migné C, Boirie Y, Walrand S,. 2012. Cumulative 3-nitrotyrosine in specific muscle proteins is associated with muscle loss during aging. Exp Gerontol 47: 129-135.
69. Murphy E, Kohr M, Sun J, Nguyen T, Steenbergen C,. 2012. S-Nitrosylation: A radical way to protect the heart. J Mol Cell Cardiol 52: 568-577.
70. Nakamura T, Tu S, Akhtar MW, Sunico CR, Okamoto S, Lipton SA,. 2013. Aberrant protein S-nitrosylation in neurodegenerative diseases. Neuron 78: 596-614.
71. Oeste CC, Pérez-Sala D,. 2013. Modification of cysteine residues by cyclopentenone prostaglandins: Interplay with redox regulation of protein function. Mass Spectrom Rev 33: DOI: 10.1002/mas.21383
72. Perluigi M, Coccia R, Butterfield DA,. 2012. 4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases. Antioxid Redox Signal 17: 1590-1609.
73. Piantadosi CA,. 2012. Regulation of mitochondrial processes by protein S-nitrosylation. Biochim Biophys Acta 1820: 712-721.
74. Poole LB, Nelson KJ,. 2008. Discovering mechanisms of signaling-mediated cysteine oxidation. Curr Opin Chem Biol 12: 18-24.
75. Reed TT, Pierce WM, Jr., Turner DM, Markesbery WR, Butterfield DA,. 2009. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule. J Cell Mol Med 13: 2019-2029.
76. Reyes JF, Fu Y, Vana L, Kanaan NM, Binder LI,. 2011. Tyrosine nitration within the proline-rich region of Tau in Alzheimer's disease. Am J Pathol 178: 2275-2285.
77. Roos G, Messens J,. 2011. Protein sulfenic acid formation: From cellular damage to redox regulation. Free Radic Biol Med 51: 314-326.
78. Rudolph TK, Freeman BA,. 2009. Transduction of redox signaling by electrophile-protein reactions. Sci Signal 2: re7.
79. Sheehan D, McDonagh B, Bárcena JA,. 2010. Redox proteomics. Expert Rev Proteomics 7: 1-4.
80. Sheehan D, Rainville LC, Tyther R, McDonagh B,. 2012. Redox proteomics in study of kidney-associated hypertension: New insights to old diseases. Antioxid Redox Signal 17: 1560-1570.
81. Sies H, Jones D,. 2007. Oxidative stress. In:, Fink G, editor. Encyclopedia of stress, vol. 3, 2nd edition. San Diego: Elsevier. pp. 45-48.
82. Souza JM, Peluffo G, Radi R,. 2008. Protein tyrosine nitration-Functional alteration or just a biomarker ? Free Radic Biol Med 45: 357-366.
83. Stadtman ER, Berlett BS,. 1998. Reactive oxygen-mediated protein oxidation in aging and disease. Drug Metab Rev 30: 225-243.
84. Sultana R, Butterfield DA,. 2011. Identification of the oxidative stress proteome in the brain. Free Radic Biol Med 50: 487-494.
85. Sultana R, Poon HF, Cai J, Pierce WM, Merchant M, Klein JB, Markesbery WR, Butterfield DA,. 2006. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 22: 76-87.
86. Sultana R, Perluigi M, Newman SF, Pierce WM, Cini C, Coccia R, Butterfield DA,. 2010. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease. Antioxid Redox Signal 12: 327-336.
87. Sultana R, Perluigi M, Allan Butterfield D,. 2012. Lipid peroxidation triggers neurodegeneration: A redox proteomics view into the Alzheimer disease brain. Free Radic Biol Med pii: S0891-5849(12)01161-6, doi: 10.1016/j. freeradbiomed.2012.09.027
88. Tsikas D, Duncan M,. 2013. Mass spectrometry and 3-nitrotyrosine: Strategies, controversies and our current perspective. Mass Spectrom Rev 33: DOI: 10.1002/mas.21396
89. Uchida K, Shibata T,. 2008. 15-Deoxy-Delta(12,14)-prostaglandin J2: An electrophilic trigger of cellular responses. Chem Res Toxicol 21: 138-144.
90. Vasil'ev YV, Tzeng S-C, Huang L, Maier CS,. 2013. Protein modifications by electrophilic lipoxidation products: Adduct formation, chemical strategies and tandem mass spectrometry for their detection and identification. Mass Spectrom Rev 33: DOI: 10.1002/mas.21389
91. Zhan X, Wang X, Desiderio DM,. 2013. Pituitary adenoma nitroproteomics: Current status and perspectives. Oxid Med Cell Longev 2013: 580710.
92. Zhang Y, Du Y, Le W, Wang K, Kieffer N, Zhang J,. 2011. Redox control of the survival of healthy and diseased cells. Antioxid Redox Signal 15: 2867-2908.